Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study

Farmacia Hospitalaria - Tập 46 - Trang 372-379 - 2022
José Seijas-Amigo1,2,3, Ángel Salgado-Barreira4, Rosana Castelo-Domínguez5, Mercedes Pereira-Pía6, Moisés Rodríguez-Mañero1,2, José Ramón González-Juanatey1,2
1Cardiology Department. Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña. Spain
2Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)
3Fundación IDIS de Santiago de Compostela, A Coruña. Spain
4Unidad de Epidemiología e Investigación Clínica, Universidad de Santiago de Compostela, A Coruña. Spain
5Pharmacy Department, Centro de Salud de Ribeira, A Coruña. Spain
6Pharmacy Department, Centro de Salud de San Roque, Lugo. Spain

Thông tin
Thông tin xuất bản

Farmacia Hospitalaria

Tập 46

372-379

Thông tin tác giả